Experimental Study of Inhibitory Effects of Angiostatin on Glioma Line G 422
Wenzhi Zhang
Abstract
Wenzhi Zhang
Abstract
Objective: To study the inhibitory effects of angiostatin (AS) on glioma line G422. Methods: The effects of AS on the proliferation of angioendothelial cell line ECV-304 and human glioma cell line TJ-905 were observed with MTT method. The mouse model was established for subcutaneous transplantation of glioma line G422. After injection of AS [10 and 50mg/(kg·d)] for 14 days, the changes of tumor ratio and tumor inhibition rate were observed. Results: The AS inhibitionon KCV-304 cell exhibited a dose-action dependent relation with an IC (50) to be 3.7 mg/L. The inhibition rate of 50 mg/(kg·d) in vivo might be as high as 84.3% . Conclusion. The experimental study indicates that the AS will be of a wide application in tumor treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the inhibitory effects of angiostatin (AS) on glioma line G422. Methods: The effects of AS on the proliferation of angioendothelial cell line ECV-304 and human glioma cell line TJ-905 were observed with MTT method. The mouse model was established for subcutaneous transplantation of glioma line G422. After injection of AS [10 and 50mg/(kg·d)] for 14 days, the changes of tumor ratio and tumor inhibition rate were observed. Results: The AS inhibitionon KCV-304 cell exhibited a dose-action dependent relation with an IC (50) to be 3.7 mg/L. The inhibition rate of 50 mg/(kg·d) in vivo might be as high as 84.3% . Conclusion. The experimental study indicates that the AS will be of a wide application in tumor treatment.
Key concepts: Angiostatin, Glioma, In vivo, Cell culture, Inhibitory postsynaptic potential, Transplantation, Cancer research, Chemistry